Similar articles for PMID: 18625828

Year	Number of Results
2005	3
2006	21
2007	16
2008	20
2009	19
2010	16
2011	11
2012	1
2014	1
2015	1
2016	1
2023	1
2024	0

1

Bisphosphonate-associated osteonecrosis of the jaw.

Khan A. Khan A. Can Fam Physician. 2008 Jul;54(7):1019-21. Can Fam Physician. 2008. PMID: 18625828 Free PMC article. No abstract available.

2

Osteonecrosis of the jaw associated with bisphosphonate therapy.

Wirth SM, Lawson AP, Sutphin SD, Adams VR. Wirth SM, et al. Orthopedics. 2009 Dec;32(12):900. doi: 10.3928/01477447-20091020-16. Orthopedics. 2009. PMID: 20000241 No abstract available.

3

Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.

Ruggiero SL. Ruggiero SL. Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):479-87. doi: 10.1016/j.coms.2015.06.008. Epub 2015 Aug 18. Oral Maxillofac Surg Clin North Am. 2015. PMID: 26293329 Review.

4

Bisphosphonate-related osteonecrosis of the jaws an old disease with a new drug?

Carlson ER. Carlson ER. Cranio. 2010 Jan;28(1):1-2. doi: 10.1179/crn.2010.001. Cranio. 2010. PMID: 20158003 No abstract available.

5

Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.

Campisi G, Fedele S, Colella G, Lo Casto A, Fusco V. Campisi G, et al. J Rheumatol. 2009 Feb;36(2):451-3; author reply 453. doi: 10.3899/jrheum.080843. J Rheumatol. 2009. PMID: 19208579 No abstract available.

6

Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

Ruggiero SL, Fantasia J, Carlson E. Ruggiero SL, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Oct;102(4):433-41. doi: 10.1016/j.tripleo.2006.06.004. Epub 2006 Jul 31. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006. PMID: 16997108 No abstract available.

7

Managing the adverse effects of bisphosphonate therapy on the jaw.

Rizzolo D, Sedrak M. Rizzolo D, et al. JAAPA. 2009 Nov;22(11):48-52. doi: 10.1097/01720610-200911000-00014. JAAPA. 2009. PMID: 19999176 No abstract available.

8

[Osteonecrosis of the jaw].

Drozdzowska B. Drozdzowska B. Endokrynol Pol. 2011;62 Suppl 3:4-9. Endokrynol Pol. 2011. PMID: 22161980 Review. Polish.

9

Staging bisphosphonate-related osteonecrosis of the jaw should include early stages of disease.

McMahon RE, Bouquot JE, Glueck CJ, Griep JA, Adams WR, Spolnik KJ, Deardorf KA. McMahon RE, et al. J Oral Maxillofac Surg. 2007 Sep;65(9):1899-900. doi: 10.1016/j.joms.2007.04.021. J Oral Maxillofac Surg. 2007. PMID: 17719423 No abstract available.

10

Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaw?

Yarom N, Fedele S, Lazarovici TS, Elad S. Yarom N, et al. J Oral Maxillofac Surg. 2010 Mar;68(3):705. doi: 10.1016/j.joms.2009.07.086. J Oral Maxillofac Surg. 2010. PMID: 20171493 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year